Alzheimer Disease

Showing NaN - NaN of 42

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Delirium, Neurocognitive Disorders, Mild Cognitive Impairment Trial in United States (HELP, FAM-HELP)

Not yet recruiting
  • Delirium
  • +9 more
  • HELP
  • FAM-HELP
  • Orange, California
  • +6 more
Jun 28, 2023

Alzheimer Trial in Worldwide (Gantenerumab)

Active, not recruiting
  • Alzheimer Disease
  • Atlantis, Florida
  • +33 more
Jan 19, 2023

Dementia, Alzheimer, Caregiver Burnout Trial in Portland (STELLA (Support via TEchnology: Living and Learning with Advancing

Active, not recruiting
  • Dementia
  • +3 more
  • STELLA (Support via TEchnology: Living and Learning with Advancing Alzheimer's disease and related dementias)
  • Portland, Oregon
    Oregon Health and Science University, Layton Aging and Alzheimer
Oct 16, 2022

Alzheimer Trial in Japan, Puerto Rico, United States (Donanemab, Placebo)

Recruiting
  • Alzheimer Disease
  • Birmingham, Alabama
  • +215 more
Aug 9, 2022

Alzheimer Trial in Worldwide (Gantenerumab, Placebo)

Recruiting
  • Alzheimer Disease
  • Tucson, Arizona
  • +247 more
Jul 29, 2022

Alzheimer Trial in Worldwide (AL002, Placebo)

Recruiting
  • Alzheimer Disease
  • Phoenix, Arizona
  • +93 more
Jul 21, 2022

Alzheimer, Dementia of Alzheimer Type Trial in Australia, United States (ATH-1017, Placebo)

Completed
  • Alzheimer Disease
  • Dementia of Alzheimer Type
  • Santa Ana, California
  • +12 more
Jul 5, 2022

Alzheimer Trial in Canada, Puerto Rico, United States (Simufilam, Placebo)

Recruiting
  • Alzheimer Disease
  • Phoenix, Arizona
  • +76 more
Jul 1, 2022

Alzheimer Trial in Worldwide (Gantenerumab, Placebo)

Active, not recruiting
  • Alzheimer Disease
  • Phoenix, Arizona
  • +156 more
Jul 4, 2022

Dementia, Alzheimer, Relationship, Marital Trial in Portland (READyR II: A, READyR II: B)

Active, not recruiting
  • Dementia
  • +3 more
  • READyR II: A
  • READyR II: B
  • Portland, Oregon
    Oregon Health & Science University
Jun 27, 2022

Dementia, Alzheimer, Relationship, Marital Trial in Portland (READyR A, READyR B)

Completed
  • Dementia
  • +3 more
  • READyR A
  • READyR B
  • Portland, Oregon
    Oregon Health & Science University
Jun 27, 2022

Alzheimer Trial in Worldwide (Donanemab, Placebo)

Active, not recruiting
  • Alzheimer Disease
  • Hoover, Alabama
  • +282 more
Apr 6, 2022

Alzheimer Trial in United States (Bryostatin 1, Placebo)

Active, not recruiting
  • Alzheimer Disease
  • Bryostatin 1
  • Placebo
  • Colton, California
  • +18 more
Mar 28, 2022

Dementia, Alzheimer, Caregiver Burnout Trial in Portland (Tele-STELLA)

Recruiting
  • Dementia
  • +3 more
  • Tele-STELLA
  • Portland, Oregon
    Oregon Health and Science University, Layton Aging and Alzheimer
Mar 23, 2022

Alzheimer Trial in Australia, United States (ATH-1017)

Enrolling by invitation
  • Alzheimer Disease
  • Sun City, Arizona
  • +35 more
Feb 28, 2022

Alzheimer Trial in Worldwide (COR388 capsule, Placebo capsule)

Completed
  • Alzheimer Disease
  • COR388 capsule
  • Placebo capsule
  • Phoenix, Arizona
  • +92 more
Mar 8, 2022

Alzheimer Trial in United States (troriluzole, Placebo oral capsule)

Completed
  • Alzheimer Disease
  • Phoenix, Arizona
  • +43 more
Feb 15, 2022

Alzheimer Trial in Canada, United States (Azeliragon, Placebo)

Terminated
  • Alzheimer Disease
  • Tucson, Arizona
  • +32 more
Dec 21, 2021

Alzheimer Trial in Worldwide (GV-971, Placebo)

Recruiting
  • Alzheimer Disease
  • Gilbert, Arizona
  • +170 more
Dec 10, 2021

OCT Angiography and NRAI in Dementia

Recruiting
  • Alzheimer Disease
  • +2 more
  • Optical Coherence Tomography Angiography (OCTA) Imaging
  • Noninvasive Retinal Amyloid Imaging (NRAI)
  • Portland, Oregon
    Oregon Health & Science University
Mar 24, 2021

Alzheimer Trial in Portland (Neurofeedback)

Terminated
  • Alzheimer Disease
  • Neurofeedback
  • Portland, Oregon
    Oregon Health & Science University
Mar 1, 2021

Alzheimer Trial in United States (Bryostatin, Placebo)

Completed
  • Alzheimer Disease
  • Fresno, California
  • +27 more
Sep 8, 2020

Alzheimer Trial in Canada, United States (Placebo Control, ELND005)

Completed
  • Alzheimer Disease
  • Phoenix, Arizona
  • +61 more
Oct 17, 2019

Alzheimer, Cognition Disorders Trial in United States (florbetapir F 18 PET scan)

Completed
  • Alzheimer Disease
  • Cognition Disorders
  • florbetapir F 18 PET scan
  • Glendale, Arizona
  • +74 more
Oct 23, 2018

Alzheimer Trial in Worldwide (bapineuzumab, )

Terminated
  • Alzheimer Disease
  • Birmingham, Alabama
  • +286 more
May 3, 2016